Biblio
“Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.”, J Alzheimers Dis, vol. 100, no. 2, pp. 563-578, 2024.
, “Pre-existing dementia is associated with 2-3 folds risk for in-hospital mortality and complications after intracerebral hemorrhage stroke.”, J Alzheimers Dis, vol. 102, no. 2, pp. 338-346, 2024.
, “Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.”, J Alzheimers Dis, vol. 99, no. 1, pp. 85-99, 2024.
, “Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-β42.”, J Alzheimers Dis, vol. 99, no. 3, pp. 877-881, 2024.
, “Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
, “Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.”, J Alzheimers Dis, vol. 102, no. 1, pp. 228-236, 2024.
, “Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1261-1274, 2024.
, “The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug.”, J Alzheimers Dis, vol. 99, no. 1, pp. 161-175, 2024.
, “Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study.”, J Alzheimers Dis, vol. 98, no. 1, pp. 265-274, 2024.
, “A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories.”, J Alzheimers Dis, vol. 99, no. 3, pp. 843-856, 2024.
, “Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 1, pp. 31-74, 2024.
, “Short-Term Practice Effects on Cognitive Tests Across the Late Life Cognitive Spectrum and How They Compare to Biomarkers of Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. 1, pp. 321-332, 2024.
, “Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.”, J Alzheimers Dis, vol. 98, no. 2, pp. 643-657, 2024.
, “Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies.”, J Alzheimers Dis, vol. 97, no. 1, pp. 121-143, 2024.
, “Small RNA Profiles of Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S235-S248, 2024.
, “Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea.”, J Alzheimers Dis, vol. 97, no. 1, pp. 273-281, 2024.
, “Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies.”, J Alzheimers Dis, vol. 97, no. 2, pp. 567-572, 2024.
, “A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials.”, J Alzheimers Dis, vol. 102, no. 4, pp. 943-966, 2024.
, “Targeting Caspases 3/6 and Cathepsins L/B May Decrease Laminopathy-Induced Apoptosis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 101, no. 1, pp. 211-221, 2024.
, “Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Status of Trials and Insights from Preclinical Studies.”, J Alzheimers Dis, vol. 101, no. s1, pp. S129-S140, 2024.
, “There are dementia patients in Gaza too.”, J Alzheimers Dis, vol. 102, no. 2, pp. 317-320, 2024.
, “Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. 1, pp. 1-20, 2024.
, “Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors.”, J Alzheimers Dis, vol. 98, no. 2, pp. 343-360, 2024.
, “Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia.”, J Alzheimers Dis, vol. 98, no. 2, pp. 361-372, 2024.
, “Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline.”, J Alzheimers Dis, vol. 104, no. 3, pp. 667-677, 2025.
,